A case of elephantiasis nostras verrucosa treated by acitretin.
Identifieur interne : 004560 ( Main/Exploration ); précédent : 004559; suivant : 004561A case of elephantiasis nostras verrucosa treated by acitretin.
Auteurs : Mualla Polat [Turquie] ; Betül SereflicanSource :
- Journal of drugs in dermatology : JDD [ 1545-9616 ] ; 2012.
Descripteurs français
- KwdFr :
- Acitrétine (usage thérapeutique), Adulte d'âge moyen, Dermatoses de la jambe (anatomopathologie), Dermatoses de la jambe (traitement médicamenteux), Dermatoses du pied (anatomopathologie), Dermatoses du pied (traitement médicamenteux), Humains, Kératolytiques (usage thérapeutique), Lymphoedème (anatomopathologie), Lymphoedème (traitement médicamenteux), Mâle, Résultat thérapeutique, Éléphantiasis (anatomopathologie), Éléphantiasis (traitement médicamenteux).
- MESH :
- anatomopathologie : Dermatoses de la jambe, Dermatoses du pied, Lymphoedème, Éléphantiasis.
- traitement médicamenteux : Dermatoses de la jambe, Dermatoses du pied, Lymphoedème, Éléphantiasis.
- usage thérapeutique : Acitrétine, Kératolytiques.
- Adulte d'âge moyen, Humains, Mâle, Résultat thérapeutique.
English descriptors
- KwdEn :
- Acitretin (therapeutic use), Elephantiasis (drug therapy), Elephantiasis (pathology), Foot Dermatoses (drug therapy), Foot Dermatoses (pathology), Humans, Keratolytic Agents (therapeutic use), Leg Dermatoses (drug therapy), Leg Dermatoses (pathology), Lymphedema (drug therapy), Lymphedema (pathology), Male, Middle Aged, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Acitretin, Keratolytic Agents.
- drug therapy : Elephantiasis, Foot Dermatoses, Leg Dermatoses, Lymphedema.
- pathology : Elephantiasis, Foot Dermatoses, Leg Dermatoses, Lymphedema.
- Humans, Male, Middle Aged, Treatment Outcome.
Abstract
Elephantiasis nostras verrucosa is a rare disorder characterized by dermal fibrosis, hyperkeratotic, verrucous, and papillomatous lesions that result from both chronic filarial and nonfilarial lymphedema. Various treatment options have been reported for this disease. We present a 64-year-old man with erythrodermic psoriasis and elephantiasis nostras verrucosa in whom the lesions were resolved almost completely after acitretin treatment.
PubMed: 22395594
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002237
- to stream PubMed, to step Curation: 002237
- to stream PubMed, to step Checkpoint: 002237
- to stream Ncbi, to step Merge: 004B52
- to stream Ncbi, to step Curation: 004B52
- to stream Ncbi, to step Checkpoint: 004B52
- to stream Main, to step Merge: 004583
- to stream Main, to step Curation: 004560
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of elephantiasis nostras verrucosa treated by acitretin.</title>
<author><name sortKey="Polat, Mualla" sort="Polat, Mualla" uniqKey="Polat M" first="Mualla" last="Polat">Mualla Polat</name>
<affiliation wicri:level="1"><nlm:affiliation>Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Bolu, Turkey. polatmualla@gmail.com</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Bolu</wicri:regionArea>
<wicri:noRegion>Bolu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sereflican, Betul" sort="Sereflican, Betul" uniqKey="Sereflican B" first="Betül" last="Sereflican">Betül Sereflican</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22395594</idno>
<idno type="pmid">22395594</idno>
<idno type="wicri:Area/PubMed/Corpus">002237</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002237</idno>
<idno type="wicri:Area/PubMed/Curation">002237</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002237</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002237</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002237</idno>
<idno type="wicri:Area/Ncbi/Merge">004B52</idno>
<idno type="wicri:Area/Ncbi/Curation">004B52</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004B52</idno>
<idno type="wicri:doubleKey">1545-9616:2012:Polat M:a:case:of</idno>
<idno type="wicri:Area/Main/Merge">004583</idno>
<idno type="wicri:Area/Main/Curation">004560</idno>
<idno type="wicri:Area/Main/Exploration">004560</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A case of elephantiasis nostras verrucosa treated by acitretin.</title>
<author><name sortKey="Polat, Mualla" sort="Polat, Mualla" uniqKey="Polat M" first="Mualla" last="Polat">Mualla Polat</name>
<affiliation wicri:level="1"><nlm:affiliation>Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Bolu, Turkey. polatmualla@gmail.com</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Bolu</wicri:regionArea>
<wicri:noRegion>Bolu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sereflican, Betul" sort="Sereflican, Betul" uniqKey="Sereflican B" first="Betül" last="Sereflican">Betül Sereflican</name>
</author>
</analytic>
<series><title level="j">Journal of drugs in dermatology : JDD</title>
<idno type="ISSN">1545-9616</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acitretin (therapeutic use)</term>
<term>Elephantiasis (drug therapy)</term>
<term>Elephantiasis (pathology)</term>
<term>Foot Dermatoses (drug therapy)</term>
<term>Foot Dermatoses (pathology)</term>
<term>Humans</term>
<term>Keratolytic Agents (therapeutic use)</term>
<term>Leg Dermatoses (drug therapy)</term>
<term>Leg Dermatoses (pathology)</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (pathology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acitrétine (usage thérapeutique)</term>
<term>Adulte d'âge moyen</term>
<term>Dermatoses de la jambe (anatomopathologie)</term>
<term>Dermatoses de la jambe (traitement médicamenteux)</term>
<term>Dermatoses du pied (anatomopathologie)</term>
<term>Dermatoses du pied (traitement médicamenteux)</term>
<term>Humains</term>
<term>Kératolytiques (usage thérapeutique)</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Éléphantiasis (anatomopathologie)</term>
<term>Éléphantiasis (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Acitretin</term>
<term>Keratolytic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Dermatoses de la jambe</term>
<term>Dermatoses du pied</term>
<term>Lymphoedème</term>
<term>Éléphantiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis</term>
<term>Foot Dermatoses</term>
<term>Leg Dermatoses</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Elephantiasis</term>
<term>Foot Dermatoses</term>
<term>Leg Dermatoses</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Dermatoses de la jambe</term>
<term>Dermatoses du pied</term>
<term>Lymphoedème</term>
<term>Éléphantiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acitrétine</term>
<term>Kératolytiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Elephantiasis nostras verrucosa is a rare disorder characterized by dermal fibrosis, hyperkeratotic, verrucous, and papillomatous lesions that result from both chronic filarial and nonfilarial lymphedema. Various treatment options have been reported for this disease. We present a 64-year-old man with erythrodermic psoriasis and elephantiasis nostras verrucosa in whom the lesions were resolved almost completely after acitretin treatment.</div>
</front>
</TEI>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><noCountry><name sortKey="Sereflican, Betul" sort="Sereflican, Betul" uniqKey="Sereflican B" first="Betül" last="Sereflican">Betül Sereflican</name>
</noCountry>
<country name="Turquie"><noRegion><name sortKey="Polat, Mualla" sort="Polat, Mualla" uniqKey="Polat M" first="Mualla" last="Polat">Mualla Polat</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004560 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004560 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:22395594 |texte= A case of elephantiasis nostras verrucosa treated by acitretin. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22395594" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |